Hepatic aberrant glycosylation by N-acetylglucosaminyltransferase V accelerates HDL assembly.

Hepatic aberrant glycosylation by N-acetylglucosaminyltransferase V accelerates HDL assembly.
复制标题

DOI:
10.1152/ajpgi.00231.2016
复制
发表时间:
2016-11
期刊:
American journal of physiology. Gastrointestinal and liver physiology
影响因子:
--
通讯作者:
Y. Kamada;Sachiho Kida;K. Hirano;Satoshi Yamaguchi;A. Suzuki;Chikako Hashimoto;A. Kimura;M. Sato;Hironobu Fujii;Tomoaki Sobajima;Akiko Yamamoto;Yusuke Ebisutani;S. Takamatsu;S. Shinzaki;Y. Yoshida;Makoto Yamada;H. Nagasaka;T. Takehara;E. Miyoshi
Y. Kamada;Sachiho Kida;K. Hirano;Satoshi Yamaguchi;A. Suzuki;Chikako Hashimoto;A. Kimura;M. Sato;Hironobu Fujii;Tomoaki Sobajima;Akiko Yamamoto;Yusuke Ebisutani;S. Takamatsu;S. Shinzaki;Y. Yoshida;Makoto Yamada;H. Nagasaka;T. Takehara;E. Miyoshi
中科院分区:
其他
文献类型:
--
作者:
Y. Kamada;Sachiho Kida;K. Hirano;Satoshi Yamaguchi;A. Suzuki;Chikako Hashimoto;A. Kimura;M. Sato;Hironobu Fujii;Tomoaki Sobajima;Akiko Yamamoto;Yusuke Ebisutani;S. Takamatsu;S. Shinzaki;Y. Yoshida;Makoto Yamada;H. Nagasaka;T. Takehara;E. Miyoshi

文献摘要

相似文献

糖基化参与各种病理生理学状况。N-乙酰葡糖胺转移酶V(GnT-V)催化天冬酰胺连接的寡糖中的β1-6分支,是参与癌症和免疫系统的最重要的糖基转移酶之一。最近的研究表明,异常的N-聚糖结构可以改变脂质代谢。在这项研究中,我们研究了异常糖基化GnT-V对高密度脂蛋白胆固醇(HDL)组装的影响。我们使用GnT-V转基因(Tg)小鼠和GnT-V Hep 3B细胞(人肝癌细胞系)转染子。该研究还包括96名接受医疗健康检查的患者。与野生型(WT)小鼠相比,Tg小鼠的血清总胆固醇水平,特别是HDL-胆固醇(HDL-C)水平显著升高。与WT小鼠相比,Tg小鼠的载脂蛋白AI(ApoAI)和ATP结合盒亚家族A成员1(ABCA 1)的肝脏表达更高,这是HDL组装中的两个重要因素。ApoAI和ABCA 1也显着升高GnT-V转染细胞相比,模拟转染细胞。此外,GnT-V转染细胞培养液中的ApoAI蛋白显著增加。最后,我们发现了人类受试者血清GnT-V活性和HDL-C浓度之间的强相关性。多因素Logistic分析表明,GnT-V活性是血清HDL-C水平的独立和重要的决定因素,即使调整了年龄和性别差异。进一步的分析表明,血清GnT-V活性有很强的相关性,特别是与大尺寸HDL颗粒浓度。这些发现表明肝脏GnT-V活性增强加速了HDL组装,并且可能是HDL合成的一种新机制。
Glycosylation is involved in various pathophysiological conditions. N-Acetylglucosaminyltransferase V (GnT-V), catalyzing β1-6 branching in asparagine-linked oligosaccharides, is one of the most important glycosyltransferases involved in cancer and the immune system. Recent findings indicate that aberrant N-glycan structure can modify lipid metabolism. In this study, we investigated the effects of aberrant glycosylation by GnT-V on high-density lipoprotein cholesterol (HDL) assembly. We used GnT-V transgenic (Tg) mice and GnT-V Hep3B cell (human hepatoma cell line) transfectants. The study also included 96 patients who underwent medical health check-ups. Total serum cholesterol levels, particularly HDL-cholesterol (HDL-C) levels, were significantly increased in Tg vs. wild-type (WT) mice. Hepatic expression of apolipoprotein AI (ApoAI) and ATP-binding cassette subfamily A member 1 (ABCA1), two important factors in HDL assembly, were higher in Tg mice compared with WT mice. ApoAI and ABCA1 were also significantly elevated in GnT-V transfectants compared with mock-transfected cells. Moreover, ApoAI protein in the cultured media of GnT-V transfectants was significantly increased. Finally, we found a strong correlation between serum GnT-V activity and HDL-C concentration in human subjects. Multivariate logistic analyses demonstrated that GnT-V activity was an independent and significant determinant for serum HDL-C levels even adjusted with age and gender differences. Further analyses represented that serum GnT-V activity had strong correlation especially with the large-size HDL particle concentration. These findings indicate that enhanced hepatic GnT-V activity accelerated HDL assembly and could be a novel mechanism for HDL synthesis.